339 related articles for article (PubMed ID: 20191522)
1. Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study.
van Vollenhoven RF; Cifaldi MA; Ray S; Chen N; Weisman MH
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):226-34. PubMed ID: 20191522
[TBL] [Abstract][Full Text] [Related]
2. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT
Arthritis Rheum; 2006 Jan; 54(1):26-37. PubMed ID: 16385520
[TBL] [Abstract][Full Text] [Related]
3. Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year efficacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label extension.
Keystone EC; Breedveld FC; van der Heijde D; Landewé R; Florentinus S; Arulmani U; Liu S; Kupper H; Kavanaugh A
J Rheumatol; 2014 Jan; 41(1):5-14. PubMed ID: 24241487
[TBL] [Abstract][Full Text] [Related]
4. Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis.
Emery P; Genovese MC; van Vollenhoven R; Sharp JT; Patra K; Sasso EH
J Rheumatol; 2009 Jul; 36(7):1429-41. PubMed ID: 19369462
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study.
Strand V; Rentz AM; Cifaldi MA; Chen N; Roy S; Revicki D
J Rheumatol; 2012 Jan; 39(1):63-72. PubMed ID: 22045836
[TBL] [Abstract][Full Text] [Related]
6. Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate.
Emery P; Smolen JS; Ganguli A; Meerwein S; Bao Y; Kupper H; Chen N; Kavanaugh A
Rheumatology (Oxford); 2016 Aug; 55(8):1458-65. PubMed ID: 27114561
[TBL] [Abstract][Full Text] [Related]
7. Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA.
Kimel M; Cifaldi M; Chen N; Revicki D
J Rheumatol; 2008 Feb; 35(2):206-15. PubMed ID: 18085743
[TBL] [Abstract][Full Text] [Related]
8. Clinical consequences of delayed addition of adalimumab to methotrexate therapy over 5 years in patients with rheumatoid arthritis.
Keystone EC; Kavanaugh A; Weinblatt ME; Patra K; Pangan AL
J Rheumatol; 2011 May; 38(5):855-62. PubMed ID: 21285171
[TBL] [Abstract][Full Text] [Related]
9. Disease activity, physical function, and radiographic progression after longterm therapy with adalimumab plus methotrexate: 5-year results of PREMIER.
van der Heijde D; Breedveld FC; Kavanaugh A; Keystone EC; Landewé R; Patra K; Pangan AL
J Rheumatol; 2010 Nov; 37(11):2237-46. PubMed ID: 20889601
[TBL] [Abstract][Full Text] [Related]
10. Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis.
Keystone EC; van der Heijde D; Kavanaugh A; Kupper H; Liu S; Guérette B; Mozaffarian N
J Rheumatol; 2013 Sep; 40(9):1487-97. PubMed ID: 23818718
[TBL] [Abstract][Full Text] [Related]
11. [Adalimumab (Humira)--efficacy in rheumatoid arthritis treatment with particular reference to working ability].
Grazio S
Reumatizam; 2008; 55(2):62-7. PubMed ID: 19024278
[TBL] [Abstract][Full Text] [Related]
12. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
Keystone EC; Kavanaugh AF; Sharp JT; Tannenbaum H; Hua Y; Teoh LS; Fischkoff SA; Chartash EK
Arthritis Rheum; 2004 May; 50(5):1400-11. PubMed ID: 15146409
[TBL] [Abstract][Full Text] [Related]
13. Short-term influence of adalimumab on work productivity outcomes in patients with rheumatoid arthritis.
Zhang W; Bansback N; Guh D; Li X; Nosyk B; Marra CA; Anis AH
J Rheumatol; 2008 Sep; 35(9):1729-36. PubMed ID: 18688916
[TBL] [Abstract][Full Text] [Related]
14. Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate.
Smolen JS; van Vollenhoven RF; Florentinus S; Chen S; Suboticki JL; Kavanaugh A
Ann Rheum Dis; 2018 Nov; 77(11):1566-1572. PubMed ID: 30076156
[TBL] [Abstract][Full Text] [Related]
15. Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial.
Smolen JS; Emery P; Fleischmann R; van Vollenhoven RF; Pavelka K; Durez P; Guérette B; Kupper H; Redden L; Arora V; Kavanaugh A
Lancet; 2014 Jan; 383(9914):321-32. PubMed ID: 24168956
[TBL] [Abstract][Full Text] [Related]
16. Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER study.
Keystone EC; Haraoui B; Guérette B; Mozaffarian N; Liu S; Kavanaugh A
J Rheumatol; 2014 Feb; 41(2):235-43. PubMed ID: 24293583
[TBL] [Abstract][Full Text] [Related]
17. Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate.
Smolen JS; van der Heijde DM; Keystone EC; van Vollenhoven RF; Goldring MB; Guérette B; Cifaldi MA; Chen N; Liu S; Landewé RB
Ann Rheum Dis; 2013 Jul; 72(7):1156-62. PubMed ID: 22915617
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled, comparative study of human anti-TNF antibody adalimumab in combination with methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis.
Chen DY; Chou SJ; Hsieh TY; Chen YH; Chen HH; Hsieh CW; Lan JL
J Formos Med Assoc; 2009 Apr; 108(4):310-9. PubMed ID: 19369178
[TBL] [Abstract][Full Text] [Related]
19. Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis.
Kavanaugh A; Smolen JS; Emery P; Purcaru O; Keystone E; Richard L; Strand V; van Vollenhoven RF
Arthritis Rheum; 2009 Nov; 61(11):1592-600. PubMed ID: 19877104
[TBL] [Abstract][Full Text] [Related]
20. Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group.
Halpern MT; Cifaldi MA; Kvien TK
Ann Rheum Dis; 2009 Jun; 68(6):930-7. PubMed ID: 18829616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
